| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| UBS OCONNOR LLC | 13 | 13 | 0.04% | 0.15% | 0.37% | Q4 2014 | Q4 2017 | 13 |
| ClearBridge Investments | 9 | 9 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q4 2016 | 9 |
| Orbimed Advisors | 9 | 9 | 0.02% | 0.03% | 0.07% | Q4 2014 | Q4 2016 | 9 |
| SILVERBACK ASSET MANAGEMENT LLC | 9 | 9 | 0.41% | 1.59% | 3.02% | Q4 2014 | Q4 2016 | 9 |
| Telemetry Investments, L.L.C. | 7 | 1 | 0.33% | 1.82% | 3.76% | Q4 2014 | Q4 2017 | 9 |
| Citadel Advisors | 6 | 2 | 0.00% | 0.00% | 0.01% | Q4 2014 | Q4 2016 | 8 |
| WOLVERINE ASSET MANAGEMENT LLC | 8 | 8 | 0.02% | 0.14% | 0.32% | Q4 2014 | Q3 2016 | 8 |
| PFM Health Sciences, LP | 8 | 8 | 0.13% | 0.29% | 0.51% | Q4 2014 | Q3 2016 | 8 |
| PALISADE CAPITAL MANAGEMENT, LP | 8 | 8 | 0.02% | 0.04% | 0.07% | Q4 2014 | Q3 2016 | 8 |
| JPMORGAN CHASE & CO | 8 | 8 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q3 2016 | 8 |
| Partner Investment Management, L.P. | 7 | 7 | 0.16% | 0.40% | 0.70% | Q1 2015 | Q3 2016 | 7 |
| FMR LLC | 7 | 7 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q2 2016 | 7 |
| BVF INC/IL | 6 | 6 | 0.43% | 0.64% | 0.93% | Q3 2016 | Q4 2017 | 6 |
| Verition Fund Management LLC | 6 | 6 | 0.06% | 0.20% | 0.37% | Q2 2015 | Q3 2016 | 6 |
| NOMURA HOLDINGS INC | 3 | 1 | 0.00% | 0.00% | 0.01% | Q4 2014 | Q4 2016 | 6 |
| DEUTSCHE BANK AG\ | 6 | 6 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q1 2016 | 6 |
| SYMPHONY ASSET MANAGEMENT LLC | 6 | 6 | 0.09% | 0.20% | 0.35% | Q1 2015 | Q2 2016 | 6 |
| BANK OF AMERICA CORP /DE/ | 2 | 1 | 0.00% | 0.00% | 0.00% | Q2 2015 | Q3 2017 | 5 |
| CSS LLC/IL | 4 | 4 | 0.00% | 0.02% | 0.05% | Q4 2014 | Q3 2015 | 4 |
| GLG LLC | 4 | 4 | 0.10% | 0.13% | 0.15% | Q4 2016 | Q3 2017 | 4 |
| Nicholas Investment Partners, LP | 4 | 4 | 0.09% | 0.28% | 0.39% | Q4 2014 | Q3 2015 | 4 |
| WELLS FARGO & COMPANY/MN | 3 | 3 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q2 2015 | 3 |
| ADVENT CAPITAL MANAGEMENT /DE/ | 3 | 3 | 0.12% | 0.19% | 0.22% | Q4 2014 | Q2 2015 | 3 |
| Cheyne Capital Management (UK) LLP | 3 | 3 | 0.15% | 0.16% | 0.16% | Q2 2015 | Q4 2015 | 3 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2 | 2 | 0.03% | 0.04% | 0.05% | Q3 2016 | Q4 2016 | 2 |
| ALTEGRIS ADVISORS, L.L.C. | 2 | 2 | 5.40% | 6.47% | 7.53% | Q4 2014 | Q1 2015 | 2 |
| Daiwa Securities Group Inc. | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2016 | Q4 2016 | 1 |
| Jefferies Group LLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2015 | Q2 2015 | 1 |
This page lists all the filers that currently own OREXIGEN THERAPEUTICS INC or have owned OREXIGEN THERAPEUTICS INC in the past.